Lithos Energy Ltd
OTC:LITSF
Relative Value
There is not enough data to reliably calculate the relative value of LITSF.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LITSF Competitors Multiples
Lithos Energy Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
L
|
Lithos Energy Ltd
OTC:LITSF
|
65.4m USD | 0 | -2.7 | -3 | -2.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 0.2 | 55.9 | 14.2 | 14.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.1B EUR | 0.3 | 13.5 | 7.9 | 10 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.1B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.3B EUR | 1.2 | 21 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 1.2 | 23.5 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 1.6 | 25 | 12.1 | 17.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.7B USD | 2 | 22 | 12.2 | 16.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | 11.8 | -27.9 | -30 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.9 | 7.3 | 9.9 |